These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14144697)

  • 1. QUALITY CONTROL PROCEDURES FOR THE HOSPITAL PHARMACY.
    SKOLAUT MW
    Hospitals; 1964 May; 38():83-90. PubMed ID: 14144697
    [No Abstract]   [Full Text] [Related]  

  • 2. Prefilling syringes in the hospital pharmacy.
    McDonald DE; Prisco HM; Parente RJ
    Am J Hosp Pharm; 1972 Mar; 29(3):223-8. PubMed ID: 5028474
    [No Abstract]   [Full Text] [Related]  

  • 3. Guidelines for single-unit packages of drugs approved by the Board of Directors, American Society of Hospital Pharmacists December 2, 1966.
    Am J Hosp Pharm; 1967 Feb; 24(2):79-80. PubMed ID: 6040685
    [No Abstract]   [Full Text] [Related]  

  • 4. Third-party repackaging in hospital pharmacy unit dose acquisition.
    Meller RD; Pazour JA; Thomas LM; Mason SJ; Root SE; Churchill WW
    Am J Health Syst Pharm; 2010 Jul; 67(13):1108-14. PubMed ID: 20554598
    [No Abstract]   [Full Text] [Related]  

  • 5. Current challenges in European oncology pharmacy practice.
    Hoppe-Tichy T
    J Oncol Pharm Pract; 2010 Mar; 16(1):9-18. PubMed ID: 20015932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OR/pharmacy drug quality assurance.
    Thur MP
    AORN J; 1976 Mar; 23(4):624, 626, 628. PubMed ID: 1045925
    [No Abstract]   [Full Text] [Related]  

  • 7. Quality control guidelines for single unit packaging of parenterals in the hospital pharmacy.
    Patel JA; Curtis EG; Phillips GL
    Am J Hosp Pharm; 1972 Nov; 29(11):947-51. PubMed ID: 4655003
    [No Abstract]   [Full Text] [Related]  

  • 8. ASHP gears up multistep action plan regarding sterile drug products.
    Am J Hosp Pharm; 1991 Mar; 48(3):386, 389-90. PubMed ID: 2028985
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of insoluble contaminants in large-volume parental infusion fluids, II. Evaluation of the degree of contamination with insoluble particles of parenteral infusion fluids produced by the pharmaceutical industry and hospital pharmacies].
    Pawlaczyk J; Nowacka D; Wawrzyńczak D
    Acta Pol Pharm; 1982; 39(1-3):151-7. PubMed ID: 7180545
    [No Abstract]   [Full Text] [Related]  

  • 10. Quality control in admixture services.
    Zellmer WA
    Am J Hosp Pharm; 1978 May; 35(5):527-8. PubMed ID: 655175
    [No Abstract]   [Full Text] [Related]  

  • 11. Disinfectants prepared in a hospital pharmacy--assessment of their microbiological purity and antimicrobial effectiveness.
    Nkibiasala SM; Devleeschouwer MJ; Van Gansbeke B; Rost F; Dony J
    J Clin Pharm Ther; 1989 Dec; 14(6):457-64. PubMed ID: 2613772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PHARMACEUTICAL REPRESENTATIVES VIEW THE HOSPITAL PHARMACY.
    MORAVEC DF
    Hosp Manage; 1964 Aug; 98():96-106. PubMed ID: 14180172
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hospital Preparations Supporting the Medication--Status Quo and Challenges in the Future].
    Hanawa T; Oguchi T
    Yakugaku Zasshi; 2015; 135(8):929-30. PubMed ID: 26234348
    [No Abstract]   [Full Text] [Related]  

  • 14. Production of sterile fluids in hospital pharmacies.
    Gillett AP
    J Hosp Infect; 1981 Jun; 2(2):113-5. PubMed ID: 6174572
    [No Abstract]   [Full Text] [Related]  

  • 15. [Role of the hospital pharmacist in the Infection Control Committee. Exemplified by the Bichat University Hospital Center].
    Dauphin A; Farinotti R
    Agressologie; 1987 Dec; 28(12):1205-9. PubMed ID: 3450198
    [No Abstract]   [Full Text] [Related]  

  • 16. The Medicines Act 1968--its impact on the hospital pharmacist in relation to sterile products.
    Sprake JM
    Hosp Eng; 1978 Oct; 32(8):24-7. PubMed ID: 10239209
    [No Abstract]   [Full Text] [Related]  

  • 17. WHAT IS AVAILABLE IN UNIT-DOSE PACKAGES TODAY?
    MORAVEC DF
    Hosp Manage; 1965 Aug; 100():88-101. PubMed ID: 14335124
    [No Abstract]   [Full Text] [Related]  

  • 18. Perception of the role of medical-service representatives in hospitals.
    Santell JP; Birdwell SW; Scheckelhoff DJ
    Am J Hosp Pharm; 1990 Jun; 47(6):1354-9. PubMed ID: 2368731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GMP considerations in the manufacture of highly potent and potentially sensitising drug dosage forms. An inspector's view.
    Hutton RC
    Boll Chim Farm; 1987 Dec; 126(12):479-85. PubMed ID: 3455225
    [No Abstract]   [Full Text] [Related]  

  • 20. 1972 Harvey A. K. Whitney lecture on maturing.
    Heller WM
    Am J Hosp Pharm; 1972 Jul; 29(7):550-5. PubMed ID: 5068467
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.